(5)
Based solely on a Schedule 13G/A filed with the SEC on February 13, 2023 by Omega Fund IV, L.P. (“Omega Fund”), Omega Fund IV GP, L.P. (“Omega GP”), Omega Fund IV GP Manager, Ltd. (“Omega Ltd”), Otello Stampacchia (“Stampacchia”) and Anne-Mari Paster (“Paster”). Consists of (i) 3,610,478 shares of our common stock held by Omega Fund and (ii) an immediately exercisable warrant held by Omega Fund to purchase 248,672 shares of our common stock. Omega Ltd serves as the general partner of Omega GP, which serves as the general partner of Omega Fund, and each of Omega GP and Omega Ltd may be deemed to own beneficially the shares held by Omega Fund. Stampacchia and and Paster are the directors of Omega Ltd and may be deemed to beneficially own the shares held by Omega Fund. The address of the principal business office of Omega Fund, Omega GP, Omega Ltd, Stampacchia, and Paster, is c/o Omega Fund Management, LLC, 888 Boylston Street, Suite 1111, Boston, MA 02199.
(6)
Based solely on a Schedule 13G/A filed with the SEC on February 3, 2023 by BlackRock, Inc. (“BlackRock”). BlackRock has sole voting and sole dispositive power over 2,931,497 and 3,010,552 shares of our common stock, respectively. The address of BlackRock is 55 East 52nd Street, New York, NY 10055.
(7)
Consists of (i) 1,287,970 shares of our common stock and (ii) 713,120 shares of common stock underlying options that are exercisable within 60 days of June 30, 2023.
(8)
Consists of (i) 21,355 shares of our common stock and (ii) 238,458 shares of common stock underlying options that are exercisable within 60 days of June 30, 2023.
(9)
Consists of (i) 25,331 shares of our common stock and (ii) 96,561 shares of common stock underlying options that are exercisable within 60 days of June 30, 2023.
(10)
Consists entirely of 191,710 shares of common stock underlying options that are exercisable within 60 days of June 30, 2023.
(11)
Consists entirely of 90,000 shares of common stock underlying options that are exercisable within 60 days of June 30, 2023.
(12)
Consists entirely of 33,000 shares of common stock underlying options that are exercisable within 60 days of June 30, 2023.
(13)
Consists entirely of 66,000 shares of common stock underlying options that are exercisable within 60 days of June 30, 2023.
(14)
Consists of (i) 6,667 shares of our common stock and (ii) 108,889 shares of common stock underlying options that are exercisable within 60 days of June 30, 2023.
(15)
No common stock is beneficially owned as of June 30, 2023.
(16)
Consists entirely of 114,750 shares of common stock underlying options that are exercisable within 60 days of June 30, 2023.
(17)
Consists of (i) 76,500 shares of common stock underlying options that are exercisable within 60 days of June 30, 2023 and (ii) 5,115,121 securities held by affiliates of Forbion Capital Partners. Mr. Slootweg is a managing partner of Forbion Capital Partners. Mr. Slootweg disclaims beneficial ownership of all shares held of record by affiliates of Forbion Capital Partners.
(18)
Consists of (i) 3,986,921 shares of our common stock, and (ii) 3,494,152 shares of common stock underlying options and securities that are exercisable within 60 days of June 30, 2023, collectively held by our directors, (i) Sushil Patel, (ii) Pamela Esposito, (iii) Tanya Lewis, (iv) Colin Love, (v) Andrew Schwendenman, (vi) Konstantinos Xynos and (vii) Christopher Sarchi.